Kelly Huibregtse Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with ¹³¹I-metaiodobenzylguanidine — Parallel 14 Clinical Awards Session